Evidence map›Paper›PMID 36625597›Full record

ArticlemBio2023

Bioenergetic State of Escherichia coli Controls Aminoglycoside Susceptibility.

Jessica Y El Khoury, Jordi Zamarreño Beas, Allison Huguenot, Béatrice Py, Frédéric Barras

Open access · goldAbstract read
In one paragraph

Article in mBio, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jessica Y El Khoury *Département de Microbiologie, SAMe Unit, Institut Pasteur, Paris, France.
Jordi Zamarreño Beas *Laboratoire de Chimie Bactérienne UMR7283, Centre National de la Recherche, Marseille, France.
Allison HuguenotLaboratoire de Chimie Bactérienne UMR7283, Centre National de la Recherche, Marseille, France.
Béatrice PyLaboratoire de Chimie Bactérienne UMR7283, Centre National de la Recherche, Marseille, France.
Frédéric BarrasDépartement de Microbiologie, SAMe Unit, Institut Pasteur, Paris, France.ORCID 0000-0003-3458-2574
Aix-Marseille Université · FRCentre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aminoglycosides (AG) have been used against Gram-negative bacteria for decades. Yet, how bacterial metabolism and environmental conditions modify AG toxicity is poorly understood. Here, we show that the level of AG susceptibility varies depending on the nature of the respiratory chain that Escherichia coli uses for growth, i.e., oxygen, nitrate, or fumarate. We show that all components of the fumarate respiratory chain, namely, hydrogenases 2 and 3, the formate hydrogenlyase complex, menaquinone, and fumarate reductase are required for AG-mediated killing under fumarate respiratory conditions. In addition, we show that the AAA+ ATPase RavA and its Von Wildebrand domain-containing partner, ViaA, are essential for AG to act under fumarate respiratory conditions. This effect was true for all AG that were tested but not for antibiotics from other classes. In addition, we show that the sensitizing effect of RavA-ViaA is due to increased gentamicin uptake in a proton motive force-dependent manner. Interestingly, the sensitizing effect of RavA-ViaA was prominent in poor energy conservation conditions, i.e., with fumarate, but dispensable under high energy conservation conditions, i.e., in the presence of nitrate or oxygen. We propose that RavA-ViaA can facilitate uptake of AG across the membrane in low-energy cellular states.

Indexed as

Escherichia coliEscherichia coli ProteinsAdenosine TriphosphatasesAminoglycosidesAnaerobiosisAnti-Bacterial AgentsATPases Associated with Diverse Cellular ActivitiesBacteriaEnergy MetabolismFumaratesNitratesSuccinate DehydrogenaseVitamin K 2Adenosine TriphosphatasesAminoglycosidesAnti-Bacterial AgentsATPases Associated with Diverse Cellular ActivitiesEscherichia coli ProteinsFumaratesNitratesRavA protein, E coliSuccinate DehydrogenaseVitamin K 2aminoglycosidesbioenergeticsEscherichia colifumarate respirationproton motive forceRavA-ViaA

Identifiers

PMID36625597
PMCPMC9973319
OpenAlexW4313949142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.